ARCHIVES

Nevins Reverses Position, Claims Potti Manipulated Data For Basis of Clinical Trials

This article is from The Cancer Letter archive.

Vol. 38 No. 07 | February 17, 2012

Download PDF Visit The Full Archive

Related Articles

RFAs In Bladder, Prostate, Ok’d By DCBDC Advisors

March 1, 1991

Pesticides Not A Risk Factor For Long Island Breast Cancer, Study Finds

September 6, 2002

Five Years after Proton Therapy, 75-99% of Men Live Cancer-Free

February 28, 2014

ACS to Purchase $1.5 Million In animal Interferon, Offer it for Laboratory Studies

July 13, 1984

DC E Bard Approves Health Plan Study Recompetition, New Acrylonitrile Contract

March 16, 1984

FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint.

July 21, 2006